APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pravastatin

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pravastatin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025194 pages

Choose your research edition.

Industry ResearchPravastatin Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Pravastatin Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Pravastatin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pravastatin Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Pravastatin Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Pravastatin market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Pravastatin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pravastatin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pravastatin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pravastatin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pravastatin include TEVA, Shanghai Shyndec Pharmaceutical, SANDOZ, Mylan, Jiangxi Boyaseehot Pharmaceutical, North China Pharmaceutical Group, Zydus Pharmaceuticals, Upsher-Smith Laboratories and Lupin Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pravastatin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pravastatin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pravastatin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pravastatin market size, projected growth trends, production technologies, key applications, and end-use industries.

Pravastatin Segment by Company

TEVA

Shanghai Shyndec Pharmaceutical

SANDOZ

Mylan

Jiangxi Boyaseehot Pharmaceutical

North China Pharmaceutical Group

Zydus Pharmaceuticals

Upsher-Smith Laboratories

Lupin Pharmaceuticals

Hisun

Glenmark

Dr. Reddy's Laboratories

Daiichi Sankyo

Cipla Inc.

Bristol-Myers Squibb

Aurobindo Pharma

APOTEX

Accord Healthcare

Pravastatin Segment by Type

10mg Tablet

20mg Tablet

40mg Tablet

80mg Tablet

Pravastatin Segment by Application

Adults

Children

Pravastatin Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pravastatin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pravastatin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pravastatin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pravastatin market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pravastatin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Pravastatin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Pravastatin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Pravastatin Industry Trends Table 2. Pravastatin Industry Drivers Table 3. Pravastatin Industry Opportunities and Challenges Table 4. Pravastatin Industry Restraints Table 5. Global Pravastatin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Pravastatin Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Pravastatin Sales by Manufacturers (W Units) & (2021-2026) Table 8. Global Pravastatin Sales Market Share by Manufacturers Table 9. Global Pravastatin Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Pravastatin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Pravastatin Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Pravastatin Manufacturers, Product Type & Application Table 13. Global Pravastatin Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Pravastatin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 10mg Tablet Table 17. Major Manufacturers of 20mg Tablet Table 18. Major Manufacturers of 40mg Tablet Table 19. Major Manufacturers of 80mg Tablet Table 20. Global Pravastatin Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 21. Global Pravastatin Sales by Type (2021-2026) & (W Units) Table 22. Global Pravastatin Sales by Type (2027-2032) & (W Units) Table 23. Global Pravastatin Sales Market Share by Type (2021-2026) Table 24. Global Pravastatin Sales Market Share by Type (2027-2032) Table 25. Global Pravastatin Revenue by Type 2021 VS 2025 VS 2032 (W Units) Table 26. Global Pravastatin Revenue by Type (2021-2026) & (W Units) Table 27. Global Pravastatin Revenue by Type (2027-2032) & (W Units) Table 28. Global Pravastatin Revenue Market Share by Type (2021-2026) Table 29. Global Pravastatin Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Adults Table 31. Major Manufacturers of Children Table 32. Global Pravastatin Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 33. Global Pravastatin Sales by Application (2021-2026) & (W Units) Table 34. Global Pravastatin Sales by Application (2027-2032) & (W Units) Table 35. Global Pravastatin Sales Market Share by Application (2021-2026) Table 36. Global Pravastatin Sales Market Share by Application (2027-2032) Table 37. Global Pravastatin Revenue by Application 2021 VS 2025 VS 2032 (W Units) Table 38. Global Pravastatin Revenue by Application (2021-2026) & (W Units) Table 39. Global Pravastatin Revenue by Application (2027-2032) & (W Units) Table 40. Global Pravastatin Revenue Market Share by Application (2021-2026) Table 41. Global Pravastatin Revenue Market Share by Application (2027-2032) Table 42. Global Pravastatin Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 43. Global Pravastatin Sales by Region (2021-2026) & (W Units) Table 44. Global Pravastatin Sales Market Share by Region (2021-2026) Table 45. Global Pravastatin Sales Forecasted by Region (2027-2032) & (W Units) Table 46. Global Pravastatin Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Pravastatin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 48. North America Pravastatin Sales by Country (2021-2026) & (W Units) Table 49. North America Pravastatin Sales by Country (2027-2032) & (W Units) Table 50. Europe Pravastatin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 51. Europe Pravastatin Sales by Country (2021-2026) & (W Units) Table 52. Europe Pravastatin Sales by Country (2027-2032) & (W Units) Table 53. Asia Pacific Pravastatin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 54. Asia Pacific Pravastatin Sales by Country (2021-2026) & (W Units) Table 55. Asia Pacific Pravastatin Sales by Country (2027-2032) & (W Units) Table 56. South America, Middle East and Africa Pravastatin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 57. South America, Middle East and Africa Pravastatin Sales by Country (2021-2026) & (W Units) Table 58. South America, Middle East and Africa Pravastatin Sales by Country (2027-2032) & (W Units) Table 59. Global Pravastatin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Pravastatin Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Pravastatin Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Pravastatin Revenue Market Share by Region (2021-2026) Table 63. Global Pravastatin Revenue Market Share by Region (2027-2032) Table 64. TEVA Company Information Table 65. TEVA Business Overview Table 66. TEVA Pravastatin Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. TEVA Pravastatin Product Portfolio Table 68. TEVA Recent Development Table 69. Shanghai Shyndec Pharmaceutical Company Information Table 70. Shanghai Shyndec Pharmaceutical Business Overview Table 71. Shanghai Shyndec Pharmaceutical Pravastatin Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Shanghai Shyndec Pharmaceutical Pravastatin Product Portfolio Table 73. Shanghai Shyndec Pharmaceutical Recent Development Table 74. SANDOZ Company Information Table 75. SANDOZ Business Overview Table 76. SANDOZ Pravastatin Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. SANDOZ Pravastatin Product Portfolio Table 78. SANDOZ Recent Development Table 79. Mylan Company Information Table 80. Mylan Business Overview Table 81. Mylan Pravastatin Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Mylan Pravastatin Product Portfolio Table 83. Mylan Recent Development Table 84. Jiangxi Boyaseehot Pharmaceutical Company Information Table 85. Jiangxi Boyaseehot Pharmaceutical Business Overview Table 86. Jiangxi Boyaseehot Pharmaceutical Pravastatin Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Jiangxi Boyaseehot Pharmaceutical Pravastatin Product Portfolio Table 88. Jiangxi Boyaseehot Pharmaceutical Recent Development Table 89. North China Pharmaceutical Group Company Information Table 90. North China Pharmaceutical Group Business Overview Table 91. North China Pharmaceutical Group Pravastatin Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. North China Pharmaceutical Group Pravastatin Product Portfolio Table 93. North China Pharmaceutical Group Recent Development Table 94. Zydus Pharmaceuticals Company Information Table 95. Zydus Pharmaceuticals Business Overview Table 96. Zydus Pharmaceuticals Pravastatin Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Zydus Pharmaceuticals Pravastatin Product Portfolio Table 98. Zydus Pharmaceuticals Recent Development Table 99. Upsher-Smith Laboratories Company Information Table 100. Upsher-Smith Laboratories Business Overview Table 101. Upsher-Smith Laboratories Pravastatin Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Upsher-Smith Laboratories Pravastatin Product Portfolio Table 103. Upsher-Smith Laboratories Recent Development Table 104. Lupin Pharmaceuticals Company Information Table 105. Lupin Pharmaceuticals Business Overview Table 106. Lupin Pharmaceuticals Pravastatin Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Lupin Pharmaceuticals Pravastatin Product Portfolio Table 108. Lupin Pharmaceuticals Recent Development Table 109. Hisun Company Information Table 110. Hisun Business Overview Table 111. Hisun Pravastatin Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Hisun Pravastatin Product Portfolio Table 113. Hisun Recent Development Table 114. Glenmark Company Information Table 115. Glenmark Business Overview Table 116. Glenmark Pravastatin Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Glenmark Pravastatin Product Portfolio Table 118. Glenmark Recent Development Table 119. Dr. Reddy's Laboratories Company Information Table 120. Dr. Reddy's Laboratories Business Overview Table 121. Dr. Reddy's Laboratories Pravastatin Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Dr. Reddy's Laboratories Pravastatin Product Portfolio Table 123. Dr. Reddy's Laboratories Recent Development Table 124. Daiichi Sankyo Company Information Table 125. Daiichi Sankyo Business Overview Table 126. Daiichi Sankyo Pravastatin Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Daiichi Sankyo Pravastatin Product Portfolio Table 128. Daiichi Sankyo Recent Development Table 129. Cipla Inc. Company Information Table 130. Cipla Inc. Business Overview Table 131. Cipla Inc. Pravastatin Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Cipla Inc. Pravastatin Product Portfolio Table 133. Cipla Inc. Recent Development Table 134. Bristol-Myers Squibb Company Information Table 135. Bristol-Myers Squibb Business Overview Table 136. Bristol-Myers Squibb Pravastatin Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. Bristol-Myers Squibb Pravastatin Product Portfolio Table 138. Bristol-Myers Squibb Recent Development Table 139. Aurobindo Pharma Company Information Table 140. Aurobindo Pharma Business Overview Table 141. Aurobindo Pharma Pravastatin Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 142. Aurobindo Pharma Pravastatin Product Portfolio Table 143. Aurobindo Pharma Recent Development Table 144. APOTEX Company Information Table 145. APOTEX Business Overview Table 146. APOTEX Pravastatin Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 147. APOTEX Pravastatin Product Portfolio Table 148. APOTEX Recent Development Table 149. Accord Healthcare Company Information Table 150. Accord Healthcare Business Overview Table 151. Accord Healthcare Pravastatin Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 152. Accord Healthcare Pravastatin Product Portfolio Table 153. Accord Healthcare Recent Development Table 154. Key Raw Materials Table 155. Raw Materials Key Suppliers Table 156. Pravastatin Distributors List Table 157. Pravastatin Customers List Table 158. Research Programs/Design for This Report Table 159. Authors List of This Report Table 160. Secondary Sources Table 161. Primary Sources List of Figures Figure 1. Pravastatin Product Image Figure 2. Global Pravastatin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pravastatin Market Size (2021-2032) & (US$ Million) Figure 4. Global Pravastatin Sales (2021-2032) & (W Units) Figure 5. Global Pravastatin Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Pravastatin Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 10mg Tablet Image Figure 9. 20mg Tablet Image Figure 10. 40mg Tablet Image Figure 11. 80mg Tablet Image Figure 12. Global Pravastatin Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 13. Global Pravastatin Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Pravastatin Sales Market Share by Type (2021-2032) Figure 15. Global Pravastatin Revenue by Type (2021 VS 2025 VS 2032) & (W Units) Figure 16. Global Pravastatin Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Pravastatin Revenue Market Share by Type (2021-2032) Figure 18. Adults Image Figure 19. Children Image Figure 20. Global Pravastatin Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 21. Global Pravastatin Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Pravastatin Sales Market Share by Application (2021-2032) Figure 23. Global Pravastatin Revenue by Application (2021 VS 2025 VS 2032) & (W Units) Figure 24. Global Pravastatin Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Pravastatin Revenue Market Share by Application (2021-2032) Figure 26. North America Pravastatin Sales and Growth Rate (2021-2032) & (W Units) Figure 27. North America Pravastatin Sales Market Share by Country (2021-2032) Figure 28. U.S. Pravastatin Sales and Growth Rate (2021-2032) & (W Units) Figure 29. Canada Pravastatin Sales and Growth Rate (2021-2032) & (W Units) Figure 30. Mexico Pravastatin Sales and Growth Rate (2021-2032) & (W Units) Figure 31. Europe Pravastatin Sales and Growth Rate (2021-2032) & (W Units) Figure 32. Europe Pravastatin Sales Market Share by Country (2021-2032) Figure 33. Germany Pravastatin Sales and Growth Rate (2021-2032) & (W Units) Figure 34. France Pravastatin Sales and Growth Rate (2021-2032) & (W Units) Figure 35. U.K. Pravastatin Sales and Growth Rate (2021-2032) & (W Units) Figure 36. Italy Pravastatin Sales and Growth Rate (2021-2032) & (W Units) Figure 37. Netherlands Pravastatin Sales and Growth Rate (2021-2032) & (W Units) Figure 38. Asia Pacific Pravastatin Sales and Growth Rate (2021-2032) & (W Units) Figure 39. Asia Pacific Pravastatin Sales Market Share by Country (2021-2032) Figure 40. China Pravastatin Sales and Growth Rate (2021-2032) & (W Units) Figure 41. Japan Pravastatin Sales and Growth Rate (2021-2032) & (W Units) Figure 42. South Korea Pravastatin Sales and Growth Rate (2021-2032) & (W Units) Figure 43. Southeast Asia Pravastatin Sales and Growth Rate (2021-2032) & (W Units) Figure 44. India Pravastatin Sales and Growth Rate (2021-2032) & (W Units) Figure 45. Australia Pravastatin Sales and Growth Rate (2021-2032) & (W Units) Figure 46. South America, Middle East and Africa Pravastatin Sales and Growth Rate (2021-2032) & (W Units) Figure 47. South America, Middle East and Africa Pravastatin Sales Market Share by Country (2021-2032) Figure 48. Brazil Pravastatin Sales and Growth Rate (2021-2032) & (W Units) Figure 49. South Africa Pravastatin Sales and Growth Rate (2021-2032) & (W Units) Figure 50. Saudi Arabia Pravastatin Sales and Growth Rate (2021-2032) & (W Units) Figure 51. Turkey Pravastatin Sales and Growth Rate (2021-2032) & (W Units) Figure 52. Argentina Pravastatin Sales and Growth Rate (2021-2032) & (W Units) Figure 53. UAE Pravastatin Sales and Growth Rate (2021-2032) & (W Units) Figure 54. Egypt Pravastatin Sales and Growth Rate (2021-2032) & (W Units) Figure 55. Chile Pravastatin Sales and Growth Rate (2021-2032) & (W Units) Figure 56. Global Pravastatin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Pravastatin Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Pravastatin Revenue (2021-2032) & (US$ Million) Figure 59. North America Pravastatin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Pravastatin Revenue (2021-2032) & (US$ Million) Figure 61. Europe Pravastatin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Pravastatin Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Pravastatin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Pravastatin Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Pravastatin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Pravastatin Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Pravastatin Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 10mg Tablet
  • 20mg Tablet
  • 40mg Tablet
  • 80mg Tablet
Applications
  • Adults
  • Children
Companies covered
  • TEVA
  • Shanghai Shyndec Pharmaceutical
  • SANDOZ
  • Mylan
  • Jiangxi Boyaseehot Pharmaceutical
  • North China Pharmaceutical Group
  • Zydus Pharmaceuticals
  • Upsher-Smith Laboratories
  • Lupin Pharmaceuticals
  • Hisun
  • Glenmark
  • Dr. Reddy's Laboratories
  • Daiichi Sankyo
  • Cipla Inc.
  • Bristol-Myers Squibb
  • Aurobindo Pharma
  • APOTEX
  • Accord Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pravastatin Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pravastatin Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Pravastatin Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Pravastatin Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Pravastatin Market Dynamics
  1. 2.1 Pravastatin Industry Trends
  2. 2.2 Pravastatin Industry Drivers
  3. 2.3 Pravastatin Industry Opportunities and Challenges
  4. 2.4 Pravastatin Industry Restraints
3 Pravastatin Market by Manufacturers
  1. 3.1 Global Pravastatin Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Pravastatin Sales by Manufacturers (2021-2026)
  3. 3.3 Global Pravastatin Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Pravastatin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pravastatin Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Pravastatin Manufacturers, Product Type & Application
  7. 3.7 Global Pravastatin Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pravastatin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pravastatin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pravastatin Tier 1, Tier 2, and Tier 3
4 Pravastatin Market by Type
  1. 4.1 Pravastatin Type Introduction
  2. 4.1.1 10mg Tablet
  3. 4.1.2 20mg Tablet
  4. 4.1.3 40mg Tablet
  5. 4.1.4 80mg Tablet
  6. 4.2 Global Pravastatin Sales by Type
  7. 4.2.1 Global Pravastatin Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Pravastatin Sales by Type (2021-2032)
  9. 4.2.3 Global Pravastatin Sales Market Share by Type (2021-2032)
  10. 4.3 Global Pravastatin Revenue by Type
  11. 4.3.1 Global Pravastatin Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Pravastatin Revenue by Type (2021-2032)
  13. 4.3.3 Global Pravastatin Revenue Market Share by Type (2021-2032)
5 Pravastatin Market by Application
  1. 5.1 Pravastatin Application Introduction
  2. 5.1.1 Adults
  3. 5.1.2 Children
  4. 5.2 Global Pravastatin Sales by Application
  5. 5.2.1 Global Pravastatin Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Pravastatin Sales by Application (2021-2032)
  7. 5.2.3 Global Pravastatin Sales Market Share by Application (2021-2032)
  8. 5.3 Global Pravastatin Revenue by Application
  9. 5.3.1 Global Pravastatin Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Pravastatin Revenue by Application (2021-2032)
  11. 5.3.3 Global Pravastatin Revenue Market Share by Application (2021-2032)
6 Global Pravastatin Sales by Region
  1. 6.1 Global Pravastatin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pravastatin Sales by Region (2021-2032)
  3. 6.2.1 Global Pravastatin Sales by Region (2021-2026)
  4. 6.2.2 Global Pravastatin Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pravastatin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Pravastatin Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Pravastatin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Pravastatin Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Pravastatin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Pravastatin Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Pravastatin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Pravastatin Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Pravastatin Revenue by Region
  1. 7.1 Global Pravastatin Revenue by Region
  2. 7.1.1 Global Pravastatin Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Pravastatin Revenue by Region (2021-2026)
  4. 7.1.3 Global Pravastatin Revenue by Region (2027-2032)
  5. 7.1.4 Global Pravastatin Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Pravastatin Revenue (2021-2032)
  8. 7.2.2 North America Pravastatin Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Pravastatin Revenue (2021-2032)
  11. 7.3.2 Europe Pravastatin Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Pravastatin Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Pravastatin Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Pravastatin Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Pravastatin Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 TEVA
  2. 8.1.1 TEVA Company Information
  3. 8.1.2 TEVA Business Overview
  4. 8.1.3 TEVA Pravastatin Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 TEVA Pravastatin Product Portfolio
  6. 8.1.5 TEVA Recent Developments
  7. 8.2 Shanghai Shyndec Pharmaceutical
  8. 8.2.1 Shanghai Shyndec Pharmaceutical Company Information
  9. 8.2.2 Shanghai Shyndec Pharmaceutical Business Overview
  10. 8.2.3 Shanghai Shyndec Pharmaceutical Pravastatin Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Shanghai Shyndec Pharmaceutical Pravastatin Product Portfolio
  12. 8.2.5 Shanghai Shyndec Pharmaceutical Recent Developments
  13. 8.3 SANDOZ
  14. 8.3.1 SANDOZ Company Information
  15. 8.3.2 SANDOZ Business Overview
  16. 8.3.3 SANDOZ Pravastatin Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 SANDOZ Pravastatin Product Portfolio
  18. 8.3.5 SANDOZ Recent Developments
  19. 8.4 Mylan
  20. 8.4.1 Mylan Company Information
  21. 8.4.2 Mylan Business Overview
  22. 8.4.3 Mylan Pravastatin Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Mylan Pravastatin Product Portfolio
  24. 8.4.5 Mylan Recent Developments
  25. 8.5 Jiangxi Boyaseehot Pharmaceutical
  26. 8.5.1 Jiangxi Boyaseehot Pharmaceutical Company Information
  27. 8.5.2 Jiangxi Boyaseehot Pharmaceutical Business Overview
  28. 8.5.3 Jiangxi Boyaseehot Pharmaceutical Pravastatin Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Jiangxi Boyaseehot Pharmaceutical Pravastatin Product Portfolio
  30. 8.5.5 Jiangxi Boyaseehot Pharmaceutical Recent Developments
  31. 8.6 North China Pharmaceutical Group
  32. 8.6.1 North China Pharmaceutical Group Company Information
  33. 8.6.2 North China Pharmaceutical Group Business Overview
  34. 8.6.3 North China Pharmaceutical Group Pravastatin Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 North China Pharmaceutical Group Pravastatin Product Portfolio
  36. 8.6.5 North China Pharmaceutical Group Recent Developments
  37. 8.7 Zydus Pharmaceuticals
  38. 8.7.1 Zydus Pharmaceuticals Company Information
  39. 8.7.2 Zydus Pharmaceuticals Business Overview
  40. 8.7.3 Zydus Pharmaceuticals Pravastatin Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Zydus Pharmaceuticals Pravastatin Product Portfolio
  42. 8.7.5 Zydus Pharmaceuticals Recent Developments
  43. 8.8 Upsher-Smith Laboratories
  44. 8.8.1 Upsher-Smith Laboratories Company Information
  45. 8.8.2 Upsher-Smith Laboratories Business Overview
  46. 8.8.3 Upsher-Smith Laboratories Pravastatin Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Upsher-Smith Laboratories Pravastatin Product Portfolio
  48. 8.8.5 Upsher-Smith Laboratories Recent Developments
  49. 8.9 Lupin Pharmaceuticals
  50. 8.9.1 Lupin Pharmaceuticals Company Information
  51. 8.9.2 Lupin Pharmaceuticals Business Overview
  52. 8.9.3 Lupin Pharmaceuticals Pravastatin Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Lupin Pharmaceuticals Pravastatin Product Portfolio
  54. 8.9.5 Lupin Pharmaceuticals Recent Developments
  55. 8.10 Hisun
  56. 8.10.1 Hisun Company Information
  57. 8.10.2 Hisun Business Overview
  58. 8.10.3 Hisun Pravastatin Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Hisun Pravastatin Product Portfolio
  60. 8.10.5 Hisun Recent Developments
  61. 8.11 Glenmark
  62. 8.11.1 Glenmark Company Information
  63. 8.11.2 Glenmark Business Overview
  64. 8.11.3 Glenmark Pravastatin Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Glenmark Pravastatin Product Portfolio
  66. 8.11.5 Glenmark Recent Developments
  67. 8.12 Dr. Reddy's Laboratories
  68. 8.12.1 Dr. Reddy's Laboratories Company Information
  69. 8.12.2 Dr. Reddy's Laboratories Business Overview
  70. 8.12.3 Dr. Reddy's Laboratories Pravastatin Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Dr. Reddy's Laboratories Pravastatin Product Portfolio
  72. 8.12.5 Dr. Reddy's Laboratories Recent Developments
  73. 8.13 Daiichi Sankyo
  74. 8.13.1 Daiichi Sankyo Company Information
  75. 8.13.2 Daiichi Sankyo Business Overview
  76. 8.13.3 Daiichi Sankyo Pravastatin Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Daiichi Sankyo Pravastatin Product Portfolio
  78. 8.13.5 Daiichi Sankyo Recent Developments
  79. 8.14 Cipla Inc.
  80. 8.14.1 Cipla Inc. Company Information
  81. 8.14.2 Cipla Inc. Business Overview
  82. 8.14.3 Cipla Inc. Pravastatin Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Cipla Inc. Pravastatin Product Portfolio
  84. 8.14.5 Cipla Inc. Recent Developments
  85. 8.15 Bristol-Myers Squibb
  86. 8.15.1 Bristol-Myers Squibb Company Information
  87. 8.15.2 Bristol-Myers Squibb Business Overview
  88. 8.15.3 Bristol-Myers Squibb Pravastatin Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Bristol-Myers Squibb Pravastatin Product Portfolio
  90. 8.15.5 Bristol-Myers Squibb Recent Developments
  91. 8.16 Aurobindo Pharma
  92. 8.16.1 Aurobindo Pharma Company Information
  93. 8.16.2 Aurobindo Pharma Business Overview
  94. 8.16.3 Aurobindo Pharma Pravastatin Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Aurobindo Pharma Pravastatin Product Portfolio
  96. 8.16.5 Aurobindo Pharma Recent Developments
  97. 8.17 APOTEX
  98. 8.17.1 APOTEX Company Information
  99. 8.17.2 APOTEX Business Overview
  100. 8.17.3 APOTEX Pravastatin Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 APOTEX Pravastatin Product Portfolio
  102. 8.17.5 APOTEX Recent Developments
  103. 8.18 Accord Healthcare
  104. 8.18.1 Accord Healthcare Company Information
  105. 8.18.2 Accord Healthcare Business Overview
  106. 8.18.3 Accord Healthcare Pravastatin Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Accord Healthcare Pravastatin Product Portfolio
  108. 8.18.5 Accord Healthcare Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pravastatin Value Chain Analysis
  2. 9.1.1 Pravastatin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pravastatin Production Mode & Process
  6. 9.2 Pravastatin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pravastatin Distributors
  9. 9.2.3 Pravastatin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst